The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Evaluation of the impact of polyclonal infection and heteroresistance on treatment of tuberculosis patients
Open accessAbstract
Mixed strain infections of Mycobacterium tuberculosis make diagnosis, treatment, and control of tuberculosis (TB) more difficult. This study was aimed to evaluate the relationship between mixed infections, antibiotic resistance patterns and treatment of TB patients. In this study, among 2850 suspected TB clinical samples, a total of ninety-six clinical samples from 66 TB confirmed patients were subjected to the 24-locus variable-number tandem repeat method to evaluate the prevalence of mixed infections. For all studied strains, 288 colonies (three individual clones for each sample) were isolated from different colonies and separately analyzed by the Drug Susceptibility Test (DST). For all patients, follow up was done after 6 months of treatment. Based on direct 24 loci MIRU-VNTR, in the 66 TB patients, 53% (35/66) showed mixed infection. In the mixed samples, 45.71% (16/35) showed different antibiotic resistant patterns. Among the mixed infection patients, eight (22.9%; 8/35) showed treatment failure after six- month therapy. Six of these non-treated patients (75%; 6/8) had different antibiotic resistant patterns. We conclude that mixed infections, have a negative impact on treatment of TB patients especially when co-infecting M. tuberculosis strains display heteroresistance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“For diagnosed fungal infections, it may lead to persistent infections that require longer or more aggressive treatment regimens [27,28,29,30].”
From Insight into the Mechanisms and Clinical Relevance of Antifungal Heteroresistance (2025) · cites this paper as [29]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Supply, P., Allix, C., Lesjean, S., Cardoso-Oelemann, M., Rüsch-Gerdes, S., Willery, E., Savine, E., de Haas, P., van Deutekom, H., Roring, S., et al. (2006) · Journal of Clinical Microbiology · doi:10.1128/jcm.01392-06 · Cited by 1,274
Bacteremia causes hippocampal apoptosis in experimental pneumococcal meningitis
Østergaard, C., Leib, S. L., Rowland, I., & Brandt, C. T. (2010) · BMC Infectious Diseases · doi:10.1186/1471-2334-10-1 · Cited by 228
Cohen, T., van Helden, P. D., Wilson, D., Colijn, C., McLaughlin, M. M., Abubakar, I., & Warren, R. M. (2012) · Clinical Microbiology Reviews · doi:10.1128/cmr.00021-12 · Cited by 193
Zetola, N. M., Shin, S. S., Tumedi, K. A., Moeti, K., Ncube, R. T., Nicol, M. P., Collman, R. G., Klausner, J. D., & Modongo, C. (2014) · Journal of Clinical Microbiology · doi:10.1128/jcm.02489-13 · Cited by 142
Hofmann-Thiel, S., van Ingen, J., Feldmann, K., Turaev, L., Uzakova, G., Murmusaeva, G., van Soolingen, D., & Hoffmann, H. (2008) · European Respiratory Journal · doi:10.1183/09031936.00089808 · Cited by 132
Merker, M., Kohl, T. A., Roetzer, A., Trübe, L., Richter, E., Rüsch–Gerdes, S., Fattorini, L., Oggioni, M. R., Cox, H. S., Varaine, F., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0082551 · Cited by 130
Cohen, T., Wilson, D., Wallengren, K., Samuel, E. Y., & Murray, M. B. (2010) · Journal of Clinical Microbiology · doi:10.1128/jcm.01378-10 · Cited by 77
Kumar, P., Balooni, V., Sharma, B., Kapil, V., Sachdeva, K. S., & Singh, S. (2013) · Tuberculosis · doi:10.1016/j.tube.2013.10.001 · Cited by 65
Zetola, N. M., Modongo, C., Moonan, P. K., Ncube, R. T., Matlhagela, K., Sepako, E., Collman, R. G., & Bisson, G. P. (2014) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiu040 · Cited by 56
Diversity of Mycobacterium tuberculosis genotypes circulating in Ndola, Zambia
Mulenga, C., Shamputa, I. C., Mwakazanga, D. K., Kapata, N., Portaels, F., & Rigouts, L. (2010) · BMC Infectious Diseases · doi:10.1186/1471-2334-10-177 · Cited by 52
Cited by
Drug resistant tuberculosis: Implications for transmission, diagnosis, and disease management
Liebenberg, D., Gordhan, B. G., & Kana, B. D. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.943545 · Cited by 184
Cao, Y., Parmar, H., Gaur, R. L., Lieu, D., Raghunath, S., Via, N., Battaglia, S., Cirillo, D. M., Denkinger, C. M., Georghiou, S. B., et al. (2020) · Journal of Clinical Microbiology · doi:10.1128/jcm.02314-20 · Cited by 110
Relapse, re-infection and mixed infections in tuberculosis disease
McIvor, A., KOORNHOF, H. J., & Kana, B. D. (2017) · Pathogens and Disease · doi:10.1093/femspd/ftx020 · Cited by 107
Dookie, N., Ngema, S. L., Perumal, R., Naicker, N., Padayatchi, N., & Naidoo, K. (2022) · Clinical Microbiology Reviews · doi:10.1128/cmr.00180-19 · Cited by 106
Dookie, N., Khan, A., Padayatchi, N., & Naidoo, K. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.775030 · Cited by 72
Shin, S. S., Modongo, C., Baik, Y., Allender, C., Lemmer, D., Colman, R. E., Engelthaler, D. M., Warren, R. M., & Zetola, N. M. (2018) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiy480 · Cited by 67
Non- pncA Gene-Mutated but Pyrazinamide-Resistant Mycobacterium tuberculosis: Why Is That?
Werngren, J., Alm, E., & Mansjö, M. (2017) · Journal of Clinical Microbiology · doi:10.1128/jcm.02532-16 · Cited by 53
Mixed infections in tuberculosis: The missing part in a puzzle
Tarashi, S., Fateh, A., Mirsaeidi, M. S., Siadat, S. D., & Vaziri, F. (2017) · Tuberculosis · doi:10.1016/j.tube.2017.09.004 · Cited by 45
Self-citationClinical utility of target-based next-generation sequencing for drug-resistant TB
Mansoor, H., Hirani, N., Chavan, V. V., Das, M., Sharma, J., Bharati, M., Oswal, V., Iyer, A., Morales, M., Joshi, A., et al. (2023) · The International Journal of Tuberculosis and Lung Disease · doi:10.5588/ijtld.22.0138 · Cited by 42
Tarashi, S., Fateh, A., Jamnani, F. R., Siadat, S. D., & Vaziri, F. (2017) · Tuberculosis · doi:10.1016/j.tube.2017.03.005 · Cited by 26
Self-citationThe human microbiota in pulmonary tuberculosis: Not so innocent bystanders
Tarashi, S., Badi, S. A., Moshiri, A., Nasehi, M., Fateh, A., Vaziri, F., & Siadat, S. D. (2018) · Tuberculosis · doi:10.1016/j.tube.2018.10.010 · Cited by 29
Self-citationFluoroquinolone heteroresistance, antimicrobial tolerance, and lethality enhancement
Singh, A., Zhao, X., & Drlica, K. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.938032 · Cited by 26
Brown, T. S., Tang, L., Omar, S. V., Joseph, L., Meintjes, G., Maartens, G., Wasserman, S. A., Shah, N., Farhat, M. R., Gandhi, N. R., et al. (2023) · Clinical Infectious Diseases · doi:10.1093/cid/ciad596 · Cited by 25
Dreyer, V., Utpatel, C., Kohl, T. A., Barilar, I., Gröschel, M. I., Feuerriegel, S., & Niemann, S. (2020) · Scientific Reports · doi:10.1038/s41598-020-64708-8 · Cited by 21
Methods for Detecting Mycobacterial Mixed Strain Infections–A Systematic Review
Byrne, A. S., Goudreau, A., Bissonnette, N., Shamputa, I. C., & Tahlan, K. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2020.600692 · Cited by 20
Insight into the Mechanisms and Clinical Relevance of Antifungal Heteroresistance
Su, Y., Li, Y., Yi, Q., Xu, Y., Sun, T., & Li, Y. (2025) · Journal of Fungi · doi:10.3390/jof11020143 · Cited by 18
Mahomed, S., Mlisana, K. P., Cele, L. P., & Naidoo, K. (2020) · Journal of Clinical Tuberculosis and Other Mycobacterial Diseases · doi:10.1016/j.jctube.2020.100176 · Cited by 17
Chen, Y., Jiang, Q., Zou, J., Yang, T., Liu, Q., Luo, G., Gan, M., Jiang, Y. Z., Takiff, H. E., Lu, L., et al. (2021) · Tuberculosis · doi:10.1016/j.tube.2021.102120 · Cited by 16
Komakech, K., Nakiyingi, L., Fred, A., Achan, B., Joloba, M. L., Kirenga, B., & Ssengooba, W. (2024) · BMC Infectious Diseases · doi:10.1186/s12879-023-08968-5 · Cited by 15
Liu, Y., Zhang, Y., Lu, X., Wu, Z., Li, M., Zhang, R., Lu, Y., Hou, R., Ji, Y., Zhang, Q., et al. (2025) · Emerging Microbes & Infections · doi:10.1080/22221751.2025.2534656 · Cited by 15
Exosomes in tuberculosis: Still terra incognita?
Hadifar, S., Fateh, A., Yousefi, M. H., Siadat, S. D., & Vaziri, F. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27555 · Cited by 14
Self-citationKamakoli, M. K., Khanipour, S., Hadifar, S., Ghajavand, H., Farmanfarmaei, G., Fateh, A., Siadat, S. D., & Vaziri, F. (2018) · BMC Research Notes · doi:10.1186/s13104-018-3579-z · Cited by 12
Self-citationPrediction of the hidden genotype of mixed infection strains in Iranian tuberculosis patients
Kamakoli, M. K., Farmanfarmaei, G., Masoumi, M., Khanipour, S., Gharibzadeh, S., Sola, C., Fateh, A., Siadat, S. D., Refrégier, G., & Vaziri, F. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.03.056 · Cited by 12
Self-citationDesikan, P., Panwalkar, N., Punde, R. P., Khan, Z., Pauranik, A., Mirza, S. B., Chourey, M., Anand, S., & Sachdeva, K. S. (2023) · International Journal of Microbiology Research · doi:10.4103/ijmr.ijmr_607_22 · Cited by 12
Madadi-Goli, N., Ahmadi, K., Kamakoli, M. K., Azizi, M., Khanipour, S., Dizaji, S. P., Nasehi, M., Siadat, S. D., Fateh, A., & Vaziri, F. (2024) · Annals of Clinical Microbiology and Antimicrobials · doi:10.1186/s12941-024-00694-3 · Cited by 11
Self-citationMycobacterium tuberculosis polyclonal infections through treatment and recurrence
Pandey, P., Bhatnagar, A. K., Mohan, A., Sachdeva, K. S., Samantaray, J. C., Guleria, R., & Singh, U. B. (2020) · PLoS ONE · doi:10.1371/journal.pone.0237345 · Cited by 11
Determination of azithromycin heteroresistant Campylobacter jejuni in traveler’s diarrhea
Lurchachaiwong, W., Ruksasiri, S., Wassanarungroj, P., Serichantalergs, O., Bodhidatta, L., Crawford, J. M., Shrestha, S. K., & Pandey, P. (2019) · Gut Pathogens · doi:10.1186/s13099-019-0301-1 · Cited by 9
Impact of heteroresistance on treatment outcomes of people with drug-resistant TB
Crowder, R., Kato‐Maeda, M., Schwem, B. E., Tonga, A. D., Gaviola, D. M. G., Lopez, E., Valdez, C. L., Lim, A. R., Hunat, N., Sedusta, A. G., et al. (2024) · IJTLD OPEN · doi:10.5588/ijtldopen.24.0343 · Cited by 8
Marcon, D. J., Sharma, A., Souza, A. B., Barros, R. B., Andrade, V. D. G. D., Guimarães, R. J. D. P. S. E., Lima, L. N. G. C., Monteiro, L. H. M. T., Quaresma, A. J. P. G., Ribeiro, L. R., et al. (2025) · Frontiers in Microbiology · doi:10.3389/fmicb.2024.1514862 · Cited by 8
Chen, Y., Jiang, Q., Liu, Q., Gan, M., Takiff, H. E., & Gao, Q. (2023) · Microbiology Spectrum · doi:10.1128/spectrum.03570-22 · Cited by 7
Vasanthaiah, S., Verma, R., Kumar, A., Bandari, A. K., George, J., Rastogi, M., Manjunath, G. K., Sharma, J. N., Kumar, A., Subramani, J., et al. (2024) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofae320 · Cited by 6
Comparison of MIRU-VNTR genotyping between old and fresh clinical samples in tuberculosis
Kamakoli, M. K., Hadifar, S., Khanipour, S., Farmanfarmaei, G., Fateh, A., Siadat, S. D., & Vaziri, F. (2019) · Scandinavian Journal of Infectious Diseases · doi:10.1080/23744235.2019.1638963 · Cited by 6
Self-citationHeteroresistance in tuberculosis: are we missing drug-resistant bacteria hiding in plain sight?
Park, M., Satta, G., & Haldar, P. (2024) · Thorax · doi:10.1136/thorax-2024-221409 · Cited by 6
Vallejos-Sánchez, K., Taquiri-Díaz, D. A., Romero-Rodriguez, O. A., Vargas-Ruiz, A. P., Coronel, J., Ortiz, A. T., Perez-Martinez, J. L., Ochoa-Ortiz, A., Gilman, R. H., Grandjean, L., et al. (2025) · Journal of Medical Microbiology · doi:10.1099/jmm.0.002048 · Cited by 6
Schutz, C., Ward, A. M., Burton, R., Nicol, M. P., Blumenthal, L., Meintjes, G., & Kerkhoff, A. D. (2019) · Southern African Journal of HIV Medicine · doi:10.4102/sajhivmed.v20i1.978 · Cited by 5
Festa, R. A., Cockerill, F. R., Pesano, R. L., Haley, E., Luke, N., Mathur, M., Chen, X., Havrilla, J. M., Percaccio, M., Magallón, J., et al. (2025) · Antibiotics · doi:10.3390/antibiotics14020143 · Cited by 6
Ssengooba, W., Nakayita, G., Namaganda, C., & Joloba, M. L. (2018) · PLoS ONE · doi:10.1371/journal.pone.0199638 · Cited by 4
Emergence of Heteroresistance Mycobacterium Tuberculosis in Saudi Arabia
Abakur, E. H. A., Alnour, T. M. S., Abuduhier, F. M., Albalawi, F., & Alfifi, K. A. S. (2019) · Infectious Disorders - Drug Targets · doi:10.2174/1871526519666190326141550 · Cited by 4
Trinh, M. P., Shin, S. J., & Shin, M. (2025) · Journal of Clinical Microbiology · doi:10.1128/jcm.01086-25 · Cited by 3
Du, X., Shi, K., Zhang, H., & Chong, Y. (2026) · iScience · doi:10.1016/j.isci.2026.115049 · Cited by 4
Kamakoli, M. K., Khanipour, S., Masoumi, M., Ghajavand, H., Farmanfarmaei, G., Fateh, A., Siadat, S. D., & Vaziri, F. (2020) · Molecular Biology Reports · doi:10.1007/s11033-020-05257-1 · Cited by 3
Self-citationResistant Tuberculosis in HIV-Positive Patients: A Growing Public Health Threat
Safae, F. F., Maamar, M., Haja, K., Jait, N., Moussadik, Y., Jaradat, T., Ammouri, W., Moutassim, N., Harmouche, H., Tazi, Z. M., et al. (2023) · American Journal of Internal Medicine · doi:10.11648/j.ajim.20231103.15 · Cited by 3
ЛАБОРАТОРНА ДІАГНОСТИКА РЕЗИСТЕНТНИХ ФОРМ ТУБЕРКУЛЬОЗУ – ПРОБЛЕМИ ТА ПЕРСПЕКТИВИ
Motronenko, V., & Власюк, Т. (2023) · Біомедична інженерія і технологія · doi:10.20535/2617-8974.2023.12.291958 · Cited by 2
Advances in the Diagnosis of Mycobacterium tuberculosis Infection
da Silva, D. A., de Pina, L. C., Rêgo, A. M., Ferreira, N. V., Redner, P., & Antunes, L. C. M. (2018) · Springer eBooks · doi:10.1007/978-3-319-95111-9_4 · Cited by 2
Polu, V. G. P., Basireddy, S. R., Kanta, K. N. M., Roy, M., Buraga, B. W., Natarajan, K., Reddy, B. V. S., Alla, S. R., Kogila, S. V., Kumar, M. S., et al. (2025) · Journal of Pure and Applied Microbiology · doi:10.22207/jpam.19.4.38 · Cited by 1
Lavrenchuk, L., Umpeleva, T. V., Belyaev, D. V., Dianov, D. V., & Vakhrusheva, D. V. (2026) · Tuberculosis and lung diseases · doi:10.58838/2075-1230-2025-103-6-17-23 · Cited by 1
Clinical Interpretation of Drug Susceptibility Tests in Tuberculosis
Laniado-Laborín, R. (2020) · Current Respiratory Medicine Reviews · doi:10.2174/1573398x16999201007164411 · Cited by 1
Mixed tuberculosis infections in Northwest of Iran
Asgharzadeh, M., Taghinejad, Z., Mahdavipoor, B., Asgharzadeh, V., Kafil, H. S., & Rashedi, J. (2021) · Infezioni in Medicina · doi:10.53854/liim-2904-12 · Cited by 1
Santos-Lázaro, D., Vigo, A. N., Cotrina, V. V., Villar, S., Medina, A., Julcapoma, C., Pacheco, E., Alarcón, M. J., & Puyén, Z. M. (2026) · PLoS ONE · doi:10.1371/journal.pone.0352881
Gera, B., Singh, U. B., Das, B. K., Gautam, H., Mahopatra, S., Mirdha, B. R., Chaudhry, R., Kapil, A., & Bhatnagar, A. (2026) · BMC Microbiology · doi:10.1186/s12866-026-05603-6
Liu, S., Chen, D., Zhang, J., & Zhu, M. (2026) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2026.1894646
Zhang, X., Sim, E. M., Lam, C., Bustamante, A., Crighton, T., Marais, B. J., & Sintchenko, V. (2026) · medRxiv · doi:10.64898/2026.09.27.26364088
Metadata
- Authors
- Kargarpour Kamakoli, M., Sadegh, H. R., Farmanfarmaei, G., Masoumi, M., Fateh, A., Javadi, G., Rahimi Jamnani, F., Vaziri, F., & Siadat, S. D.
- Affiliations
- Islamic Azad University, Tehran (IR)
- Pasteur Institute of Iran (IR)
- Corresponding author
- Vaziri, Farzam
- ORCID
- Venue
- Scientific Reports
- Published
- 2017-01-25
- Volume
- 7
- Issue
- 1
- Pages
- 41410-41410
- ISSN
- 2045-2322 (ISSN-L)
- PMC
- PMC5264600
- OpenAlex
- W2581459208
- Cited by
- 51
- References
- 21
- Citations by year
- 2026: 5 · 2025: 7 · 2024: 5 · 2023: 6 · 2022: 4 · 2021: 2 · 2020: 8 · 2019: 4 · 2018: 6 · 2017: 4
- FWCI
- 4.63
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Scientific Reports (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- Pasteur Institute of Iran
- Topics
- Health Sciences › Medicine › Infectious Diseases › Tuberculosis Research and Epidemiology
- Health Sciences › Medicine › Epidemiology › Mycobacterium research and diagnosis
- Health Sciences › Medicine › Infectious Diseases › Infectious Diseases and Tuberculosis
- Keywords
- tuberculosis, Mycobacterium tuberculosis, co-infection, polyclonal infection, heteroresistance, antibiotic resistance, treatment failure, MIRU-VNTR, strain typing, drug susceptibility testing
- MeSH terms
- Follow-Up Studies, Humans, Mycobacterium tuberculosis, Tuberculosis, Multidrug-Resistant, Minisatellite Repeats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.